Trending Topics in Gastroenterology
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Recurrent non-malignant ampullary neoplasms, primarily adenomas, are benign tumors located at the ampulla of Vater, a critical junction where the bile duct and pancreatic duct meet and empty...
In South Korea's national colorectal cancer (CRC) screening program, the fecal immunochemical test (FIT) and colonoscopy are two key approaches, each with distinct advantages and limitations. Here's a...
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, can develop due to various etiologies. Alcohol-related liver disease (ALD) is a significant contributor to HCC, alongside...
Serum Tyrosine, Hepatocellular Carcinoma (HCC), and Mortality: Detailed Explanation What is Serum Tyrosine? Serum tyrosine is an aromatic amino acid (AAA) that plays a critical role in protein...
CEACAM6, HOXA-AS3, and miR-29a are molecular components that play significant roles in colorectal cancer (CRC) progression, diagnosis, prognosis, and potential therapeutic strategies. Below is a detailed explanation of...
CD47 expression plays a significant role in determining the survival outcomes of colorectal cancer (CRC) patients. Here's a detailed explanation of its impact: What is CD47? CD47 is...
Yes, the expression of AFP-L3 or DCP is strongly associated with poor outcomes in patients with unresectable hepatocellular carcinoma (HCC), as demonstrated by the study you referenced. Here's...
MIER2 as a Prognostic Marker in Colon Adenocarcinoma (COAD) What is MIER2? Mesoderm Induction Early Response 2 (MIER2) is a gene that has been identified to play a...
Ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation and oxidative damage, has emerged as a potential mechanism to overcome the resistance of pancreatic ductal...
The MATTERHORN trial was a global, Phase 3 study that investigated the addition of Durvalumab (an immunotherapy drug) to the standard FLOT chemotherapy regimen in patients with resectable...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.